This is a condition where your body doesn't make enough of another type of antibody called IgG. IgG helps fight infections all over your body. People with IgG deficiency might get more infections, like pneumonia or meningitis. It's usually mild, but sometimes it can be more serious.
Every report comes from a Lived member, sent anonymously.
Have you tried IVIG for IgG Deficiency?
IgG deficiency means the blood has less immunoglobulin G (IgG) than is normal for a person's age. IgG is the most plentiful antibody in the blood. Antibodies are proteins that recognize germs and help clear them, and IgG is especially important against the bacteria that cause sinus, ear and lung infections. When IgG is low, those infections tend to come more often, last longer or keep returning after antibiotics. The label covers a wide range. Some people have a modestly low level and few problems. Others have repeated infections that disrupt work, school and sleep, and repeated lung infections can eventually scar the airways (a condition called bronchiectasis). IgG deficiency is different from common variable immunodeficiency (CVID), a more severe antibody disorder in which other antibody types are also low, vaccines produce little protection, and autoimmune and other non-infectious complications are more common. A related label, IgG subclass deficiency, describes a low level of one of the four types of IgG while total IgG is normal.
Low IgG is either primary, meaning it comes from how a person's own immune system developed, or secondary, meaning something else is lowering it. In primary IgG deficiency, the antibody-making B cells do not produce enough IgG, and the reason is usually not known. Some milder antibody deficiencies can change over time, and a few people are later found to meet the criteria for CVID. Secondary causes are common and important to find, because addressing them can change the outlook. Medicines that target B cells, such as rituximab (Rituxan), and CAR T-cell therapy (a treatment that reprograms a person's own immune cells to attack certain blood cancers) often lower IgG. Long-term oral steroids, some immunosuppressants used for autoimmune disease or transplant, and certain antiseizure medicines such as carbamazepine and phenytoin can also do so. IgG can be lost from the body through the kidneys or gut in conditions that leak protein, and blood cancers such as chronic lymphocytic leukemia and multiple myeloma can reduce antibody production. Age matters too. Babies receive IgG from their mother late in pregnancy, so premature infants start with low levels. Some infants also make their own IgG slowly for a time, which is called transient hypogammaglobulinemia of infancy and usually resolves by early childhood.
Diagnosis starts with a blood test that measures the main antibody types: IgG, IgA and IgM. For adults, a typical lab reference range for IgG is roughly 700 to 1,600 milligrams per deciliter (mg/dL). A result below the lab's range for the person's age is low, and children have their own age-based ranges. Because levels can dip temporarily, for example after a course of steroids, clinicians usually repeat an abnormal result. A low number alone does not show how well the immune system is working, so the next step is to test antibody function. This usually means checking antibody levels against vaccines such as tetanus and pneumococcal vaccines, sometimes before and after a new dose, to see whether the body responds. Normal IgA and IgM levels and good vaccine responses point toward IgG deficiency rather than CVID. The clinician also reviews medicines and other conditions that could explain low IgG, and may order a chest scan when lung infections have been frequent. These tests are best completed before any antibody replacement begins. Infused antibodies show up on the same blood tests, so retesting later usually means pausing treatment for several months.
Treatment aims to prevent infections and the lung damage that repeated infections can cause. Not everyone with low IgG needs ongoing treatment. When IgG is only mildly low, vaccine responses are good and infections are infrequent, care may involve treating each infection promptly, staying up to date on vaccines and checking levels periodically. If the deficiency is secondary, the first step is to treat the cause or adjust the medicine responsible, when that is safe. For people with repeated bacterial infections, a clinician may suggest a daily or regular preventive antibiotic. This is simple and inexpensive, though it carries the usual antibiotic trade-offs such as side effects and resistance. When infections remain frequent or serious, or antibody function is clearly poor, immunoglobulin replacement therapy is the main option. It supplies IgG purified from donated plasma. It can be given into a vein (intravenous immunoglobulin, or IVIG) every three to four weeks at a clinic or at home with a nurse, or under the skin (subcutaneous immunoglobulin, or SCIG), usually weekly or every few weeks, which many people learn to do themselves at home. Both routes protect well; the choice depends on veins, schedule, side effects and preference. Replacement does not fix the body's own antibody production, so it must be repeated to keep working, and its benefit in milder forms can take months to a year to become clear. Common side effects are headache, tiredness, chills and muscle aches, more often with IVIG; serious reactions such as blood clots or kidney problems are rare. Because it is costly and supply is limited, whether and when to start is often a shared decision, and some stable people later pause treatment to see whether they still need it.
The course varies with the cause. Many people with mild primary IgG deficiency live ordinary lives with a few extra steps: acting early on infections, keeping vaccines current and seeing an immunologist (a specialist in immune disorders) for periodic blood tests. Secondary low IgG may improve after a causative medicine is stopped, though recovery after B-cell therapy can take a year or longer and sometimes does not happen. Most infants with transient low IgG reach normal levels as they grow. For people on immunoglobulin replacement, the therapy becomes a routine part of life, and infections should become less frequent and less severe, though not eliminated. Follow-up includes checking IgG levels just before a dose, tracking infections and, for those with lung involvement, monitoring lung health. Ig replacement can make live vaccines ineffective, and donated antibodies may not protect well against the newest flu and COVID-19 strains, so vaccine timing should be planned with the care team; yearly non-live flu vaccines are commonly recommended. A diagnosis is also worth revisiting over time, since a small number of people develop a broader antibody disorder.
Ask about testing if sinus, ear or lung infections keep coming back, need repeated or prolonged antibiotics, or fail to clear as expected, or if infections increase after starting a medicine known to lower antibodies. If you have IgG deficiency, contact your care team promptly when a fever, worsening cough or sinus infection begins, rather than waiting to see if it passes. Also call the prescriber if a severe headache that does not ease with over-the-counter medicine develops in the days after an IVIG infusion. Chest pain, sudden shortness of breath, sudden weakness on one side of the body, or swelling with trouble breathing during or after an immunoglobulin infusion needs emergency care right away.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with IgG Deficiency is like, what's helped you, or ask the community a question.